Literature DB >> 8233096

Muscarinic receptors mediate attenuation of extracellular acetylcholine levels in rat cerebral cortex after cholinesterase inhibition.

E Messamore1, U Warpman, E Williams, E Giacobini.   

Abstract

Muscarinic autoregulation of extracellular acetylcholine levels was investigated by microdialysis in the cerebral cortex of freely moving rats under basal conditions as well as following systemic administration of a reversible cholinesterase inhibitor. Atropine (2.2 mg/kg s.c. or 0.2 microM via the dialysis probe) did not affect basal extracellular acetylcholine levels in the cerebral cortex. However, it did potentiate the elevation of extracellular acetylcholine levels produced by a dose of systemic heptylphysostigmine which inhibited 25% of cortical and 40% of plasma cholinesterase activity. These observations suggest that the extracellular concentration of acetylcholine following moderate acetylcholinesterase inhibition is regulated through muscarinic receptors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8233096     DOI: 10.1016/0304-3940(93)90265-m

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  4 in total

Review 1.  Pharmacodynamic-tolerability relationships of cholinesterase inhibitors for Alzheimer's disease.

Authors:  B P Imbimbo
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

2.  Cholinergic modulation of a decrement in social investigation following repeated contacts between mice.

Authors:  J T Winslow; F Camacho
Journal:  Psychopharmacology (Berl)       Date:  1995-09       Impact factor: 4.530

3.  Metrifonate effects on acetylcholine and biogenic amines in rat cortex.

Authors:  F Mori; G Cuadra; E Giacobini
Journal:  Neurochem Res       Date:  1995-09       Impact factor: 3.996

Review 4.  The role of basal forebrain cholinergic neurons in fear and extinction memory.

Authors:  Dayan Knox
Journal:  Neurobiol Learn Mem       Date:  2016-06-02       Impact factor: 2.877

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.